27.11.2013 • NewsFormosaFormosa PlasticsFracking

Formosa Plastics Plans $2 Billion Ethane Cracker in Texas

One of Asia's largest chemicals and plastics producers, Taiwan-based Formosa Plastics, is seeking to cash in on the U.S. shale gas boom with its own $2 billion ethane cracker in Texas.

On a trip to Washington, D.C. as part of a Taiwanese business delegation, Formosa vice chairman Susan Wang said the company has already asked federal and state authorities for permission to expand its site at Port Comfort, Texas southwest of Houston and expects the green light within a year.

"Because of shale gas, the cost of making petrochemical- and plastic-related products is becoming very competitive here in the United States," Wang said in an interview with Bloomberg News, adding that "it's probably as cost effective as in the Middle East."

In 2012, Formosa announced that it would spend $1.7 billion on an integrated 800,000 t/y gas-fed cracker and a 300,000 t/y LDPE plant at Port Comfort, along with a 600,000 t/y dehydrogenation (PDH) plant to start up in 2016. Wang did not elaborate on what the additional $300,000 expenditure would cover.

The executive told Bloomberg that her company is "at a crossroads" in determining whether to build or invest in a naphtha cracker in the Chinese People's Republic after Taiwan last month lifted its ban on such investments.

Separately, press reports from Vietnam and Taiwan say that Formosa is planning to build a 200,000 t/y production facility for polystyrene in Vietnam's Nhon Trach industrial park, where it already produces manmade fibers, polyester and biaxially oriented polypropylene film (BOPP).

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read